Saccharated ferric oxide (SFO)-induced osteomalacia: In vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules
Authors:
- K. NohtomiKNK. Nohtomi
- H. DemuraHDH. Demura
- A. TakeuchiATA. Takeuchi
- T. KobayashiTKT. Kobayashi
- J. KazamaJKJ. Kazama
- H. OzawaHOH. Ozawa
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- 17 β-estradiol increases calcium content in fetal mouse parietal bones cultured in serum-free medium only at physiological concentrationsBone, 1996
- Progressively Increased Serum 1,25-Dihydroxyvitamin D2 Concentration in a Hypoparathyroid Patient with Protracted Hypercalcemia due to Vitamin D2 Intoxication.Endocrine Journal, 1994
- Noninvasive testing in the diagnosis of osteomalaciaThe American Journal of Medicine, 1993
- Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxideAmerican Journal of Hematology, 1993
- Gross and Separative Determination of 1.ALPHA.,25-Dihydroxyvitamin D2 and D3 in Plasma Using Calf Thymus Receptor.Journal of Nutritional Science and Vitaminology, 1993
- The biology of transferrinClinica Chimica Acta, 1990
- Bone disease in children with homozygous β-thalassemiaBone and Mineral, 1990
- Renal Lesions and Clinical Findings in Thalassemia Major and other Chronic Anemias with HemosiderosisPediatric Pathology, 1989
- Iron Transport and Storage ProteinsAnnual Review of Biochemistry, 1980
- Mechanism of 25-hydroxycholecalciferol lα-hydroxylation. Incorporation of oxygen-18 into the lα postion of 25-hydroxycholecalciferolBiochemistry, 1973